Search Results - "Rickard, Kathleen A."
-
1
Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy
Published in Chest (01-08-2001)“…Comparison of inhaled salmeterol powder vs oral montelukast treatment in patients with persistent asthma who remained symptomatic while receiving inhaled…”
Get more information
Journal Article -
2
Fractional Exhaled Nitric Oxide (FeNO) Measurements with the NIOX VERO® in Children 4 to 6 Years Old using the 6 and 10 Second Exhalation Modes
Published in Journal of allergy and clinical immunology (01-02-2018)“…Rationale This study, conducted using the NIOX VERO, assessed the feasibility and degree of agreement between FeNO measurements performed in the same subject…”
Get full text
Journal Article -
3
MISSION ABC: transforming respiratory care through one-stop multidisciplinary clinics – an observational study
Published in BMJ open (08-01-2024)“…ObjectivesThe Modern Innovative Solutions to Improve Outcomes in Asthma, Breathlessness and Chronic Obstructive Pulmonary Disease (COPD) (MABC) service aimed…”
Get full text
Journal Article -
4
Lack of Subsensitivity to Albuterol After Treatment with Salmeterol in Patients with Asthma
Published in American journal of respiratory and critical care medicine (01-05-1999)“…The development of tolerance to the bronchodilator effects of beta2-agonists used in asthma therapy has been the subject of debate. We conducted two…”
Get full text
Journal Article -
5
Efficacy of salmeterol xinafoate in the treatment of COPD
Published in Chest (01-04-1999)“…To examine and compare the efficacy and safety of salmeterol xinafoate, a long-acting inhaled beta2-adrenergic agonist, with inhaled ipratropium bromide and…”
Get more information
Journal Article -
6
Not running on empty
Published in Annals of allergy, asthma, & immunology (01-10-2006)Get more information
Journal Article -
7
Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast
Published in Annals of allergy, asthma, & immunology (01-05-2003)“…The safety and efficacy of intranasal corticosteroids for the treatment of allergic rhinitis is well documented in the literature. Additionally, an expert…”
Get more information
Journal Article -
8
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
Published in Journal of allergy and clinical immunology (01-06-2000)“…Background: Few studies have compared the efficacy of inhaled corticosteroids and leukotriene modifiers for the treatment of persistent asthma. Objective: Our…”
Get full text
Journal Article -
9
No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year
Published in Allergy and asthma proceedings (01-11-2002)“…This randomized, double-blind, placebo-controlled study of fluticasone propionate aqueous nasal spray (at a maximum recommended dose of 200 micrograms each…”
Get more information
Journal Article -
10
-
11
The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis
Published in Allergy and asthma proceedings (01-09-2003)“…Intranasal corticosteroids have been shown to decrease ocular symptoms associated with allergic rhinitis as well as nasal symptoms. The primary objective of…”
Get more information
Journal Article -
12
Lack of Effect of Fluticasone Propionate Aqueous Nasal Spray on the Hypothalamic-Pituitary-Adrenal Axis in 2- and 3-Year-Old Patients
Published in Pediatrics (Evanston) (01-07-2003)“…Fluticasone propionate aqueous nasal spray (FP) at the highest recommended doses does not affect hypothalamic-pituitary-adrenal (HPA) axis function in adults…”
Get full text
Journal Article -
13
ENSIFENTRINE IMPROVED SYMPTOMS AND QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE COPD REGARDLESS OF SMOKING STATUS
Published in Chest (01-10-2024)Get full text
Journal Article -
14
ENSIFENTRINE IMPROVED LUNG FUNCTION, SYMPTOMS, AND QUALITY OF LIFE REGARDLESS OF COPD SEVERITY
Published in Chest (01-10-2024)Get full text
Journal Article -
15
ENSIFENTRINE IMPROVED SYMPTOMS AND QUALITY OF LIFE IN PATIENTS WITH COPD REGARDLESS OF BRONCHITIS HISTORY
Published in Chest (01-10-2024)Get full text
Journal Article -
16
ENSIFENTRINE, A NOVEL COPD TREATMENT, REDUCED COPD-RELATED HEALTHCARE RESOURCE UTILIZATION OVER 48 WEEKS
Published in Chest (01-10-2024)Get full text
Journal Article -
17
ENSIFENTRINE IMPROVED LUNG FUNCTION IN PATIENTS WITH MODERATE TO SEVERE COPD: A POOLED ANALYSIS FROM THE PHASE 3 ENHANCE TRIALS
Published in Chest (01-10-2024)Get full text
Journal Article -
18
Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age
Published in Annals of allergy, asthma, & immunology (01-04-2002)“…There are limited published data describing the relative efficacy of available treatment options in younger versus older patients with persistent asthma. To…”
Get more information
Journal Article -
19
Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma
Published in Annals of allergy, asthma, & immunology (01-02-2002)“…Asthma is a chronic disease characterized by inflammation and bronchoconstriction. Medications that are able to effectively treat both components are…”
Get more information
Journal Article -
20
Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia
Published in Annals of allergy, asthma, & immunology (01-04-2002)“…Although response to intranasal corticosteroid therapy has been reported in patients with nonallergic rhinitis with eosinophilic syndrome (NARES), efficacy…”
Get more information
Journal Article